Precigen (STU:I5X) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 01, 2026)


STU:I5X Precigen Inc STU:I5X
62 GF Score
Price €4.92
GF Value €5.31
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Precigen Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Precigen's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

STU:I5X vs KARD, SLBT, GENB: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Precigen's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precigen Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precigen's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Precigen's Margin of Safety % (DCF FCF Based) falls into.


STU:I5X
62GF Score
Precigen Inc STU:I5X
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Precigen (STU:I5X) Overvalued in 2026?

Based on GuruFocus' analysis, Precigen stock appears to be undervalued. The current stock price of €4.92 is trading 7.3% below its estimated GF Value™ of €5.31. GuruFocus considers Precigen to be Fairly Valued.

Key valuation signals for STU:I5X:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €5.31 vs. price of €4.92 (7.3% below fair value)
  • GF Score™: 62/100 with 10 warning signs

No single metric tells the full story. See the STU:I5X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precigen Business Description

Other Exchanges PGEN:USA
Address 20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
62GF Score

Get the complete analysis for STU:I5X

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.92
Price
€5.31
GF Value